318 related articles for article (PubMed ID: 7337980)
1. Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis.
Schifferli JA; Morris SM; Dash A; Peters DK
Clin Exp Immunol; 1981 Dec; 46(3):557-64. PubMed ID: 7337980
[TBL] [Abstract][Full Text] [Related]
2. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
3. The effect of sera of patients with systemic lupus erythematosus on artificial immune complexes.
Bányai A; Szabó G; Csongor J; Sonkoly I; Szegedi G
Acta Med Hung; 1985; 42(1-2):51-7. PubMed ID: 4034337
[TBL] [Abstract][Full Text] [Related]
4. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
Tomooka K
Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
[TBL] [Abstract][Full Text] [Related]
5. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera.
Balestrieri G; Pagani D; Tincani A
J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608
[TBL] [Abstract][Full Text] [Related]
6. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
7. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
Adu D; Williams DG
Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
[TBL] [Abstract][Full Text] [Related]
8. Direct stimulation of neutrophil oxygenation activity by serum from patients with systemic lupus erythematosus: a relationship to disease activity.
Via CS; Allen RC; Welton RC
J Rheumatol; 1984 Dec; 11(6):745-53. PubMed ID: 6520828
[TBL] [Abstract][Full Text] [Related]
9. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
[TBL] [Abstract][Full Text] [Related]
10. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
Baatrup G; Petersen I; Jensenius JC; Svehag SE
Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
[TBL] [Abstract][Full Text] [Related]
11. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
[TBL] [Abstract][Full Text] [Related]
13. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
Meryhew NL; Kimberly RP; Messner RP; Runquist OA
J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
[TBL] [Abstract][Full Text] [Related]
14. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
[TBL] [Abstract][Full Text] [Related]
15. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
[TBL] [Abstract][Full Text] [Related]
16. Circulating immune complexes in lupus erythematosus, scleroderma and dermatomyositis.
Sølling J; Sølling K; Jacobsen KU
Acta Derm Venereol; 1979; 59(5):421-6. PubMed ID: 93365
[TBL] [Abstract][Full Text] [Related]
17. Solubilization of intraglomerular deposits of IgG immune complexes by human sera or gamma-globulin in patients with lupus nephritis.
Tomino Y; Sakai H; Takaya M; Miura M; Suga T; Endoh M; Nomoto Y
Clin Exp Immunol; 1984 Oct; 58(1):42-8. PubMed ID: 6206971
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
19. Patients with systemic lupus erythematosus are deficient in complement-dependent prevention of immune precipitation.
Arason GJ; Steinsson K; Kolka R; Víkingsdóttir T; D'Ambrogio MS; Valdimarsson H
Rheumatology (Oxford); 2004 Jun; 43(6):783-9. PubMed ID: 15054157
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of immune complex solubilization: complement function in relation to disease activity in SLE.
Sturfelt G; Nived O; Sjöholm AG
Clin Exp Rheumatol; 1992; 10(3):241-7. PubMed ID: 1582069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]